India provides a 31-month period for PCT national-phase entry. The current WIPO Applicant's Guide identifies English translation requirements where needed, Form 1 as the preferred national-phase form, and an Indian address for service.
| Patent office | Indian Patent Office |
|---|---|
| Entry deadline | 31 months from the priority date under the current WIPO PCT Applicant's Guide. |
| Language / translation | English translation is required where the international application was not filed or published in English. |
| Representation | An agent is not mandatory under the current WIPO guide, but an address for service in India is required; if an agent is appointed, authorization is filed in the prescribed manner. |
| Portfolio question | India can be significant for software, telecom, pharmaceuticals, biotech, engineering, energy, manufacturing and a rapidly expanding technology market. |
This page separates current office procedure from filing strategy. Deadlines, fees and office requirements can change, so consequential filing decisions should be checked against the official sources listed below.
The current WIPO PCT Applicant's Guide for India states that the time limit for national-phase entry is 31 months from the priority date under both the Article 22 and Article 39 routes. India should therefore be placed on a 31-month filing calendar, with an earlier internal deadline for forms, translation and claim review.
The WIPO guide states that the Indian Patent Office has Form 1 for providing national-phase application details and that the form should preferably be used. Applicants should use the current official forms and fee schedule because Indian patent rules and filing requirements can change.
The current WIPO guide requires an English translation where the international application was not filed or published in English. The translation covers the relevant description, claims, drawing text and abstract, including treatment of amendments where applicable. Translation accuracy should be verified because the national-phase application proceeds from the filed material.
The WIPO guide states that representation by an agent is not mandatory for every applicant, but an address for service in India is required. If an agent is appointed, written authorization is filed. Foreign applicants should therefore plan the service-address and local-prosecution workflow before the deadline.
The current WIPO guide states that the Indian Patent Office does not permit reinstatement of rights under PCT Rule 49.6. This makes national-phase deadline control particularly important. Applicants should not assume that a missed deadline can routinely be repaired.
India requires a request for examination; the current WIPO guide describes the applicable request period under Indian law. A national-phase filing alone does not mean substantive examination will automatically begin. Examination timing should be managed as part of the prosecution strategy.
The WIPO guide describes a requirement to file a statement concerning corresponding foreign applications. Applicants should coordinate this information obligation with their global portfolio records so national-phase prosecution remains consistent with applications elsewhere.
India can be commercially important for software, telecom, pharmaceuticals, biotech, engineering, clean technology and manufacturing. Some technology areas also raise India-specific patentability issues, so claim strategy should be reviewed against Indian law rather than simply importing the international claim set.
Retain India where market growth, manufacturing, licensing, competitor activity, R&D or enforcement value justifies the prosecution cost. The decision should also consider technology-specific patentability, expected claim scope and the importance of India within the applicant’s Asia strategy.
Before entering the national phase in India, re-check the controlling deadline, translation requirements, required application documents, representation rules, official fees and any available restoration or extension mechanism against the current patent-office or WIPO materials linked on this page. A national-phase decision should also confirm that the application being entered is the correct international application and that the claims, description and drawings support the commercial product. Procedural accuracy and portfolio value are separate questions, so both should be reviewed before fees are committed.
Entry into India should be tied to a commercial reason. Relevant evidence can include expected revenue, manufacturing, technically significant infrastructure, competitors, licensees, investors, regulated-market access and the location of acts that could support infringement evidence. A large market is not automatically a high-value patent market for every invention. The strongest decision record states what commercial leverage the right is expected to create and what portfolio cost will be required through prosecution and maintenance.
The PCT application may contain broad claims, but the commercially useful position in India can depend on who performs the claimed steps and how the product is deployed. Server-side, device, system, composition, method or manufacturing claims can create different enforcement positions depending on the technology. Before examination begins, identify the product features that matter, the likely competitor implementation and the evidence that could later show use of the claimed invention.
The national-phase deadline is not only a procedural event. It is a natural point to review product-market fit, licensing discussions, competitor activity, financing, technical changes and prior-art developments. If the invention has changed materially since the priority filing, prosecution strategy should be adjusted within the support available in the original disclosure. Jurisdictions that no longer support a clear business objective can be removed, allowing budget to move toward stronger markets or newer inventions.
Before acting on this page, identify the exact decision it is meant to support, the official source that controls any procedural requirement, the technical or commercial evidence that justifies the chosen jurisdiction, and the next deadline or document required. A clear decision record should also state what would cause the strategy to change. This makes the research usable during later prosecution, national-phase selection, budgeting and portfolio review rather than leaving it as a static summary.
Before acting on this page, identify the exact decision it is meant to support, the official source that controls any procedural requirement, the technical or commercial evidence that justifies the chosen jurisdiction, and the next deadline or document required. A clear decision record should also state what would cause the strategy to change. This makes the research usable during later prosecution, national-phase selection, budgeting and portfolio review rather than leaving it as a static summary.
Before acting on this page, identify the exact decision it is meant to support, the official source that controls any procedural requirement, the technical or commercial evidence that justifies the chosen jurisdiction, and the next deadline or document required. A clear decision record should also state what would cause the strategy to change. This makes the research usable during later prosecution, national-phase selection, budgeting and portfolio review rather than leaving it as a static summary.
Use current official requirements together with market, technology, manufacturing, licensing, competitor and enforcement considerations before committing to long-term portfolio cost.
rd (at) patentbusinesslawyer (dot) com
This national-phase guide explains entering the jurisdiction. For the separate question of taking an invention originating here into foreign markets, Read the origin-country international filing guide.
